Chronic urticaria: a comparison of management guidelines

Bibliography

• Zuberbier T, Asero R, Bindslev-Jensen C, EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009;12:1417-26
   Google Scholar
• DuBuske L. Desloratadine for chronic idiopathic urticaria. Am J Clin Dermatol 2007;8:271-83
   PubMed Web of Science ®Google Scholar
• Zuberbier T, Asero R, Bindslev-Jensen C, EAACI/GA2LEN/EDF/WAO guideline: management of urticaria. Allergy 2009;64:1427-43
   PubMed Web of Science ®Google Scholar
• Greaves MW. Chronic urticaria. N Engl J Med 1995;332:1767-72
   PubMed Web of Science ®Google Scholar
• van der Valk PG, Moret G, Kiemeney LA. The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral center. Br J Dermatol 2002;146:110-13
   PubMed Web of Science ®Google Scholar
• Baiardini I, Giardini A, Pasquali M, Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 2003;58:621-3
   PubMed Web of Science ®Google Scholar
• O'Donnell BF, Lawlor F, Simpson J, The impact of chronic urticaria on the quality of life. Br J Dermatol 1997;136:197-201
   PubMed Web of Science ®Google Scholar
• Caine N, Harrison SCW, Sharples LD, Wallwork J. Prospective study of quality of life before and after coronary artery bypass grafting. BMJ 1991;302:511-16
   PubMed Web of Science ®Google Scholar
• Powell RJ, Du Toit GL, Siddique N, for the British Society for Allergy and Clinical Immunology (BSACI). BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007;37:631-50
   PubMed Web of Science ®Google Scholar
• Tedeschi A, Girolomoni G, Asero R. AAITO position paper: chronic urticaria: diagnostic workup and treatment. Eur Ann Allergy Clin Immunol 2007;39:225-31
   Google Scholar
• Societe Francaise de Dermatologie. Consensus conference. Management of chronic urticaria. Wednesday 8 January 2003. Institut Pasteur – Paris, France. Recommendations (short version). Eur J Dermatol 2003;13:385-92
   Google Scholar
• Wanderer AA, Bernstein IL, Goodman DL, The diagnosis and management of urticaria: a practice parameter. Ann Allergy Asthma Immunol 2000;85:i-viii. 521-44
   Google Scholar
• Grattan CEH, Humphreys F; on behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 2007;157:1116-23
   PubMed Web of Science ®Google Scholar
• Khan DA. Chronic urticaria: diagnosis and management. Allergy Asthma Proc 2008;29:439-46
   PubMed Web of Science ®Google Scholar
• Muller BA. Urticaria and angioedema: a practical approach. Am Fam Physician 2004;69:1123-8
   PubMed Web of Science ®Google Scholar
• Riedl M, Ortiz G, Casillas AM. A primary care guide to managing chronic urticaria. J Am Acad Physician Assist 2003;16:1-13
   Google Scholar
• Kaplan AP. Chronic urticaria and angioedema. N Engl J Med 2002;346:175-9
   PubMed Web of Science ®Google Scholar
• Młynek A, Maurer M, Zalewska A. Update on chronic urticaria: focusing on mechanisms. Curr Opin Allergy Clin Immunol 2008;8:433-7
   PubMed Web of Science ®Google Scholar
• Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004;114:465-74
   PubMed Web of Science ®Google Scholar
• Grob JJ, Auquier P, Dreyfus I, Ortonne JP. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life. Allergy 2009;64:605-12
   PubMed Web of Science ®Google Scholar
• Potter PC, Kapp A, Maurer M, Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Allergy 2009;64:596-604
   PubMed Web of Science ®Google Scholar
• Grob JJ, Auquier P, Dreyfus I, Ortonne JP. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicenter, placebo-controlled study. J Eur Acad Dermatol Venereol 2008;22:87-93
   PubMed Web of Science ®Google Scholar
• Grob JJ, Lachapelle JM. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes. Curr Med Res Opin 2008;24:2423-8
   PubMed Web of Science ®Google Scholar
• Gimenez-Arnau A, Pujol RM, Ianosi S, for the Rupatadine Urticaria Study Group. Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study. Allergy 2007;62:539-46
   PubMed Web of Science ®Google Scholar
• Ortonne J-P, Grob J-J, Auquier P, Dreyfus I. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria. Am J Clin Dermatol 2007;8:37-42
   PubMed Web of Science ®Google Scholar
• Spector SL, Shikiar R, Harding G, The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. Cutis 2007;79:157-62
   PubMed Web of Science ®Google Scholar
• Kapp A, Demarteau N. Cost effectiveness of levocetirizine in chronic idiopathic urticaria: a pooled analysis of two randomised controlled trials. Clin Drug Investig 2006;26:1-11
   PubMed Web of Science ®Google Scholar
• Kapp A, Pichler WJ. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. Int J Dermatol 2006;45:469-74
   PubMed Web of Science ®Google Scholar
• Lachapelle JM, Decroix J, Henrijean A, Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 2006;20:288-92
   PubMed Web of Science ®Google Scholar
• Nettis E, Colanardi MC, Barra L, Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2006;154:533-8
   PubMed Web of Science ®Google Scholar
• Pfaar O, Wrede H, Barth C, Levocetirizine in patients with chronic idiopathic urticaria: results of a multicenter clinical practice study. Int J Clin Pharmacol Ther 2006;44:191-2
   Google Scholar
• Seidenari S, Cirillo A, Amoroso S, for the Italian Study Group on Desloratadine (DL) in Chronic Urticaria. Desloratadine 5 mg once daily improves quality of life in chronic idiopathic urticaria. G Ital Dermatol Venereol 2006;141:207-14
   Google Scholar
• Kaplan AP, Spector SL, Meeves S, Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Ann Allergy Asthma Immunol 2005;94:662-9
   PubMed Web of Science ®Google Scholar
• Handa S, Dogra S, Kumar B. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. J Dermatolog Treat 2004;15:55-7
   PubMedGoogle Scholar
• Kapp A, Wedi B. Chronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizine. J Drugs Dermatol 2004;3:632-9
   PubMedGoogle Scholar
• Monroe E, Finn A, Patel P, for the Desloratadine Urticaria Study Group. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 2003;48:535-41
   PubMed Web of Science ®Google Scholar
• Kawashima M, Harada S, Tango T. Review of fexofenadine in the treatment of chronic idiopathic urticaria. Int J Dermatol 2002;41:701-6
   PubMed Web of Science ®Google Scholar
• Ring J, Hein R, Gauger A. Desloratadine in the treatment of chronic idiopathic urticaria. Allergy 2001;56(Suppl 65):28-32
   Google Scholar
• Ring J, Hein R, Gauger A, for the Desloratadine Study Group. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Int J Dermatol 2001;40:72-6
   PubMed Web of Science ®Google Scholar
• Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000;84:517-22
   PubMed Web of Science ®Google Scholar
• Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol 2000;43:24-30
   PubMed Web of Science ®Google Scholar
• Finn AF, Kaplan AP, Fretwell R, A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1999;103:1071-8
   Google Scholar
• Dubretret L, Murrieta Aguttes M, Tonet J; for the MILOR Study Group. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study. J Eur Acad Dermatol Venereol 1999;12:16-24
   Google Scholar
• Monroe EW. Loratadine in the treatment of urticaria. Clin Ther 1997;19:232-42
   PubMed Web of Science ®Google Scholar
• Breneman DL. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother 1996;30:1075-9
   PubMed Web of Science ®Google Scholar
• Brostoff J, Fitzharris P, Dunmore C, Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria. Allergy 1996;51:320-5
   PubMed Web of Science ®Google Scholar
• Breneman D, Bronsky EA, Bruce S, Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol 1995;33:192-8
   PubMed Web of Science ®Google Scholar
• Staevska M, Popov T, Kralimjarkova T, The effectiveness of antihistamines in up to four-times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol 2010;125:676-82
   PubMed Web of Science ®Google Scholar
• Siebenhaar F, Degener F, Zuberbier T, High-dose desloratadine decreases wheal volume and improves cold provocation thresholds as compared with standard dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 2009;123:672-9
   PubMed Web of Science ®Google Scholar
• Kameyoshi Y, Tanaka T, Mihara S, Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients. Br J Dermatol 2007;157:803-4
   Google Scholar
• Asero R. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses. Clin Exp Dermatol 2007;32:34-8
   PubMed Web of Science ®Google Scholar
• Tashiro M, Sakurada Y, Iwabuchi K, Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. J Clin Pharmacol 2004;44:890-900
   PubMed Web of Science ®Google Scholar
• Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy 2002;32:133-9
   PubMed Web of Science ®Google Scholar
• Jauregui I, Ferrer M, Montoro J, Antihistamines in the treatment of chronic urticaria. J Investig Allergol Clin Immunol 2007;17(Suppl 2):41-52
   Google Scholar
• Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 2000;105(Suppl):S622-7
   Google Scholar
• Kay GC, Berman B, Mockoviak SH, Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance. Arch Intern Med 1997;157:2350-6
   PubMed Web of Science ®Google Scholar
• Bleehen SS, Thomas SE, Greaves MW, Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br J Dermatol 1987;117:81-8
   PubMed Web of Science ®Google Scholar
• Monroe EW, Cohen SH, Kalbfleisch J, Schulz CI. Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol 1981;117:404-7
   PubMed Web of Science ®Google Scholar
• Runge JW, Martinez JC, Caravati EM, Histamine antagonists in the treatment of acute allergic reactions. Ann Emerg Med 1992;21:237-42
   PubMed Web of Science ®Google Scholar
• Simons FE, Sussman GL, Simons KJ. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol 1995;95:685-93
   PubMed Web of Science ®Google Scholar
• Wan KS. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. J Dermatolog Treat 2008;20:1-4
   Google Scholar
• McBayne TO, Siddall OM. Montelukast treatment of urticaria. Ann Pharmacother 2006;40:939-42
   PubMed Web of Science ®Google Scholar
• Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 2004;113:134-40
   PubMed Web of Science ®Google Scholar
• Di Lorenzo G, Pacor ML, Mansuerto P, Is there a role for antileukotrienes in urticaria? Clin Exp Dermatol 2006;31:327-34
   PubMedGoogle Scholar
• Nettis E, Colanardi MC, Pradiso MT, Ferrannini A. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy 2004;34:1401-7
   PubMed Web of Science ®Google Scholar
• Greaves MW, Tan KT. Chronic urticaria: recent advances. Clin Rev Allergy Immunol 2007;33:134-43
   PubMed Web of Science ®Google Scholar
• Engin B, Ozdemir M. Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 2008;22:481-6
   PubMed Web of Science ®Google Scholar
• Asero R, Tedeschi A. Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. J Investig Allergol Clin Immunol 2010;20:386-90
   PubMed Web of Science ®Google Scholar
• Groffik A, Mitzel-Kaoukhov H, Magerl M, Omalizumab–an effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy 2011;66:303-5
   PubMed Web of Science ®Google Scholar
• Magerl M, Staubach P, Altrichter S, Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab. J Allergy Clin Immunol 2010;126:665-6
   PubMed Web of Science ®Google Scholar
• Kaplan AP, Joseph K, Maykut RJ, Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 2008;122:569-73
   PubMed Web of Science ®Google Scholar
• Al-Ahmad M. Omalizumab therapy in three patients with chronic autoimmune urticaria. Ann Saudi Med 2010;30:478-81
   PubMed Web of Science ®Google Scholar
• Iemoli E, Piconi S, Fusi A, Immunological effects of omalizumab in chronic urticaria: a case report. J Investig Allergol Clin Immunol 2010;20:252-4
   PubMed Web of Science ®Google Scholar
• Vestergaard C, Deleuran M. Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab. Acta Derm Venereol 2010;90:443-4
   PubMed Web of Science ®Google Scholar
• Grattan CE, O'Donnell BF, Francis DM, Randomized double-blind study of cyclosporine in chronic ‘idiopathic’ urticaria. Br J Dermatol 2000;143:365-72
   PubMed Web of Science ®Google Scholar
• Di Gioacchino M, Di Stefano F, Cavallucci E, Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc 2003;24:285-90
   PubMed Web of Science ®Google Scholar
• Serhat I, Ozturk S, Akcali C, Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation. J Dermatol 2008;35:276-82
   Google Scholar
• Vena GA, Cassano N, Colombo D, Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 2006;55:705-9
   PubMed Web of Science ®Google Scholar
• Criado RF, Criado PR, Martins JE, Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features. J Dermatolog Treat 2008;19:92-6
   PubMed Web of Science ®Google Scholar
• Cassano N, D'Argento V, Filotico R, Vena GA. Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study. Acta Derm Venereol 2005;85:254-5
   PubMed Web of Science ®Google Scholar
• Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol 2008;100:403-12
   PubMed Web of Science ®Google Scholar
• Di Lorenzo G, Pacor ML, Mansueto P, Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 2004;114:619-25
   PubMed Web of Science ®Google Scholar
• Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 2002;110:484-8
   PubMed Web of Science ®Google Scholar
• Reimers A, Pichler C, Helbling A, Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Exp Allergy 2002;32:1763-8
   PubMed Web of Science ®Google Scholar
• Pacor ML, Di Lorenzo G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy 2001;31:1607-14
   PubMed Web of Science ®Google Scholar
• Perez A, Woods A, Grattan CE. Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria. Br J Dermatol 2010;162:191-4
   PubMed Web of Science ®Google Scholar
• Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 2. Ann Allergy Asthma Immunol 2008;100:517-26
   PubMed Web of Science ®Google Scholar
• Shahar E, Bergman R, Guttman-Yassky E, Pollack S. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. Int J Dermatol 2006;45:1224-7
   PubMed Web of Science ®Google Scholar
• Bernstein JA, Garramone SM, Lower EG. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide. Ann Allergy Asthma Immunol 2002;89:212-14
   PubMed Web of Science ®Google Scholar
• Jaffer AM. Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria. J Allergy Clin Immunol 1991;88:964-5
   PubMed Web of Science ®Google Scholar
• Reeves GE, Boyle MJ, Bonfield J, Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 2004;34:182-6
   PubMed Web of Science ®Google Scholar
• Kessel A, Bamberger E, Toubi E. Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study. J Am Acad Dermatol 2005;52:145-8
   PubMed Web of Science ®Google Scholar
• Madan V, Griffiths CE. Systemic ciclosporin and tacrolimus in dermatology. Dermatol Ther 2007;20:239-50
   PubMed Web of Science ®Google Scholar
• McGirt LY, Vasagar K, Gober LM, Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol 2006;142:1337-42
   PubMedGoogle Scholar
• Morgan M. Treatment of refractory chronic urticaria with sirolimus. Arch Dermatol 2009;145:637-9
   PubMedGoogle Scholar
• Ferrer M, Jauregui I, Bartra J, Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts. Br J Dermatol 2009;160:823-7
   PubMed Web of Science ®Google Scholar
• Maurer M, Ortonne J-P, Zuberbier T. Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor–patient relation. Allergy 2009;64:581-8
   PubMed Web of Science ®Google Scholar